Unknown

Dataset Information

Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme.


ABSTRACT:

Objective

Population screening programmes must make good use of resources for the health system and users. To evaluate impacts of the type of diagnostic test in the new French cervical screening programme, an messenger ribonucleic acid (mRNA) high-risk human papillomavirus assay was compared to a deoxyribonucleic acid (DNA) high-risk human papillomavirus assay for a hypothetical cohort of women aged 25 to 65 years.

Perspective

This evaluation takes the perspective of the French healthcare system.

Setting

France.

Methods

A decision tree model reflecting the French cervical screening algorithms was parametrised using French cost and population data and the Danish Horizon study. The outcomes were total costs, and number of colposcopies, HPV tests and cytology test

SUBMITTER: Dombrowski CA 

PROVIDER: S-EPMC9302372 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature